The FDA has approved the CytoCell KMT2A Breakapart FISH Probe Kit PDx as a companion diagnostic (CDx) to accompany revumenib (Revuforj), a first-in-class Menin inhibitor for the treatment of relapsed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback